GETI_B: Strong EMEA growth, innovation, and margin expansion offset China headwinds and inflation

The discussion highlighted robust growth in EMEA, stable U.S. demand, and ongoing challenges in China. Product innovation, especially in acute care and life sciences, supports margin expansion, while quality costs are expected to decline by 2028.Based on Getinge AB Class B [GETI_B] Morgan Stanley 2…